Takeda Pharmaceutical Company Limited

TSE:4502 Stok Raporu

Piyasa değeri: JP¥6.8t

Takeda Pharmaceutical Yönetim

Yönetim kriter kontrolleri 2/4

Takeda Pharmaceutical CEO'su Christophe Weber, Jun2014 tarihinde atandı, in görev süresi 10.42 yıldır. in toplam yıllık tazminatı ¥ 2.08B olup, şirket hissesi ve opsiyonları dahil olmak üzere 15.2% maaş ve 84.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.05% ine doğrudan sahiptir ve bu hisseler ¥ 3.38B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.1 yıl ve 8.4 yıldır.

Anahtar bilgiler

Christophe Weber

İcra Kurulu Başkanı

JP¥2.1b

Toplam tazminat

CEO maaş yüzdesi15.2%
CEO görev süresi10.4yrs
CEO sahipliği0.05%
Yönetim ortalama görev süresi7.1yrs
Yönetim Kurulu ortalama görev süresi8.4yrs

Son yönetim güncellemeleri

Recent updates

Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 04
Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Sep 24
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Sep 20
Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Aug 08
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 02
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Jul 25
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Jun 30
Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

May 21
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

May 12
Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Mar 28
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Mar 13
Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Feb 26
Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

CEO Tazminat Analizi

Christophe Weber'un ücretlendirmesi Takeda Pharmaceutical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

JP¥290b

Jun 30 2024n/an/a

JP¥150b

Mar 31 2024JP¥2bJP¥317m

JP¥144b

Dec 31 2023n/an/a

JP¥178b

Sep 30 2023n/an/a

JP¥192b

Jun 30 2023n/an/a

JP¥301b

Mar 31 2023JP¥2bJP¥295m

JP¥317b

Dec 31 2022n/an/a

JP¥275b

Sep 30 2022n/an/a

JP¥213b

Jun 30 2022n/an/a

JP¥197b

Mar 31 2022JP¥2bJP¥281m

JP¥230b

Dec 31 2021n/an/a

JP¥439b

Sep 30 2021n/an/a

JP¥473b

Jun 30 2021n/an/a

JP¥431b

Mar 31 2021JP¥2bJP¥267m

JP¥376b

Dec 31 2020n/an/a

JP¥181b

Sep 30 2020n/an/a

JP¥56b

Jun 30 2020n/an/a

JP¥120b

Mar 31 2020JP¥2bJP¥273m

JP¥44b

Dec 31 2019n/an/a

JP¥13b

Sep 30 2019n/an/a

JP¥83b

Jun 30 2019n/an/a

JP¥64b

Mar 31 2019JP¥2bJP¥269m

JP¥135b

Dec 31 2018n/an/a

JP¥110b

Sep 30 2018n/an/a

JP¥141b

Jun 30 2018n/an/a

JP¥120b

Mar 31 2018JP¥1bJP¥254m

JP¥187b

Tazminat ve Piyasa: Christophe 'nin toplam tazminatı ($USD 13.75M ), JP pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.40M ).

Tazminat ve Kazançlar: Christophe 'in maaşı son bir yılda %20'den fazla arttı.


CEO

Christophe Weber (58 yo)

10.4yrs

Görev süresi

JP¥2,083,000,000

Tazminat

Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Christophe Weber
President10.4yrsJP¥2.08b0.050%
¥ 3.4b
Seigo Izumo
Chair of Management Boardno dataVeri yokVeri yok
Milano Furuta
CFO & Directorless than a yearVeri yok0.00083%
¥ 56.6m
Haruhiko Hirate
Member of Management Boardno dataVeri yokVeri yok
Salvatore Alesci
Member of Management Board and Head of R&D Global Science & Biomedical Policyno dataVeri yokVeri yok
Norimasa Takeda
Chief Accounting Officer & Corporate Controllerno dataVeri yokVeri yok
Iwaaki Taniguchi
Senior Vice President of Corporate Finance & Controlling Department11.7yrsVeri yokVeri yok
Gabriele Ricci
Chief Data & Technology Officer2.8yrsVeri yokVeri yok
Christopher David O'Reilly
Global Head of Investor Relations & Global Finance4.2yrsVeri yokVeri yok
Yoshihiro Nakagawa
Global General Counsel10.1yrsVeri yokVeri yok
Mwana Lugogo
Chief Ethics & Compliance Officer10.1yrsVeri yokVeri yok
Lauren Duprey
Chief Human Resources Officer3.8yrsVeri yokVeri yok

7.1yrs

Ortalama Görev Süresi

51.5yo

Ortalama Yaş

Deneyimli Yönetim: 4502 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.1 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Christophe Weber
President10.4yrsJP¥2.08b0.050%
¥ 3.4b
Milano Furuta
CFO & Directorno dataVeri yok0.00083%
¥ 56.6m
Andrew S. Plump
President of Research & Development and Representative Director9.4yrsJP¥972.00m0.0087%
¥ 595.1m
John M. Maraganore
Independent External Director2.4yrsJP¥32.00mVeri yok
Steven S. Gillis
Independent External Director5.8yrsJP¥44.00m0.00026%
¥ 17.7m
Emiko Higashi
Independent External Director8.4yrsJP¥49.00m0.00016%
¥ 10.9m
Yoshiaki Fujimori
Independent External Director8.4yrsJP¥40.00m0.00079%
¥ 53.8m
Ian T. Clark
Independent External Director5.8yrsJP¥44.00m0.000070%
¥ 4.8m
Jean-Luc Butel
Independent External Director5.4yrsJP¥38.00mVeri yok
Michel Orsinger
Independent External Director8.4yrsJP¥46.00mVeri yok
Masami Iijima
Independent External Chair3.4yrsJP¥43.00m0.000020%
¥ 1.4m
Koji Hatsukawa
Independent External Director8.4yrsJP¥43.00m0.00063%
¥ 42.9m

8.4yrs

Ortalama Görev Süresi

66.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4502 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.4 yıldır).